Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.
Dividend history for Hualan Biological Engineering Inc. (002007.SZ)
Hualan Biological Engineering Inc. made a total of 19 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.80
Dividend payments for Hualan Biological Engineering Inc. (002007.SZ) from 2005 to 2024
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| June 14, 24 | $0.04 | $0.04 |
| June 14, 23 | $0.04 | $0.04 |
| June 16, 22 | $0.03 | $0.03 |
| June 23, 21 | $0.04 | $0.04 |
| April 27, 20 | $0.06 | $0.06 |
| June 17, 19 | $0.06 | $0.03 |
| June 27, 18 | $0.04 | $0.02 |
| June 13, 17 | $0.06 | $0.03 |
| June 07, 16 | $0.06 | $0.02 |
| June 05, 15 | $0.08 | $0.03 |
| June 20, 14 | $0.06 | $0.02 |
| June 24, 13 | $0.01 | $0.00 |
| July 13, 12 | $0.02 | $0.01 |
| June 16, 11 | $0.04 | $0.01 |
| May 27, 10 | $0.03 | $0.01 |
| May 06, 09 | $0.03 | $0.00 |
| October 24, 07 | $0.03 | $0.00 |
| May 08, 06 | $0.04 | $0.00 |
| May 23, 05 | $0.05 | $0.00 |